4:10 pm Gilead Sciences: European Medicines Agency validates Gilead’s Marketing Application for Ledipasvir/Sofosbuvir fixed-dose combination tablet for Genotype 1 Chronic Hepatitis C Infection
View todays social media effects on GILD
View the latest stocks trending across Twitter. Click to view dashboard
See who Gilead is hiring next, click here to view
